<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Physiology of growth hormone</title><link href="/z/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/z/d/css/icofont.min.css" rel="stylesheet"/><link href="/z/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/z/d/css/animate.css" rel="stylesheet"/><link href="/z/d/css/owl.carousel.css" rel="stylesheet"/><link href="/z/d/css/magnific-popup.css" rel="stylesheet"/><link href="/z/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/z/d/css/style.css" rel="stylesheet"/><link href="/z/d/css/rtl_edited.css" rel="stylesheet"/><link href="/z/d/css/responsive.css" rel="stylesheet"/><link href="https:///uptodate_assets/main.css" rel="stylesheet"/>
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>
<meta content="" name="description"/>
<link href="/z/d/img/favicon.png" rel="icon" type="image/png">
</link></head>
<body>
<!-- Start Main Menu Area -->
<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>
<section class="teacher-area ptb-10">
<div class="container">
</div>
<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Physiology of growth hormone</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Physiology of growth hormone</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Shlomo Melmed, MD</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Peter J Snyder, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Kathryn A Martin, MD</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Jun 28, 2023.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Growth hormone (GH) is produced by the pituitary somatotroph cells. GH production begins early in fetal life and continues throughout life, although at a progressively lower rate.</p><p>The basic aspects of GH physiology will be reviewed here. This discussion will include the GH gene, the mechanisms and regulators of GH secretion, and a summary of the actions of GH. The physiology of insulin-like growth factor 1 (IGF-1), which mediates most peripheral actions of GH, is discussed separately. (See  <a class="medical medical_review" href="/z/d/html/3801.html" rel="external">"Physiology of insulin-like growth factor 1"</a>.)</p><p>Clinical issues related to GH excess (acromegaly) or GH deficiency in children and adults are also presented separately. (See  <a class="medical medical_review" href="/z/d/html/5843.html" rel="external">"Treatment of growth hormone deficiency in children"</a> and  <a class="medical medical_review" href="/z/d/html/5855.html" rel="external">"Pituitary gigantism"</a> and  <a class="medical medical_review" href="/z/d/html/6641.html" rel="external">"Growth hormone deficiency in adults"</a> and  <a class="medical medical_review" href="/z/d/html/6633.html" rel="external">"Causes and clinical manifestations of acromegaly"</a>.)</p><p class="headingAnchor" id="H2"><span class="h1">GH GENE</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>GH gene family </strong>– The human growth hormone (GH) gene family comprises five distinct genes, all located on chromosome 17q22 [<a href="#rid1">1</a>]. The pituitary GH gene (<em>GH1</em>) encodes two alternatively spliced mRNA products, which give rise to the abundant circulating 22 kDa GH molecule and a less abundant (10 percent of circulating GH) 20 kDa GH lacking amino acids 32 to 46. Placental syncytiotrophoblast cells express a GH variant (hGH-V), as well as three other genes for human chorionic somatotropin (hCS). During pregnancy, maternal GH secretion declines and is replaced by rising placental-derived GH. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Regulation of pituitary </strong><strong><em>GH1</em></strong><strong> gene</strong> <strong>–</strong> Regulation of the pituitary <em>GH1</em> gene appears to be under complex hormonal, developmental, and tissue-specific control mediated by regulatory elements of the gene [<a href="#rid2">2</a>]. The tissue-specific development of somatotrophs and expression of GH appear to be largely determined by the POU1F1 (Pit-1) transcription factor [<a href="#rid3">3</a>]. (See  <a class="medical medical_review" href="/z/d/html/2900.html" rel="external">"Basic genetics concepts: DNA regulation and gene expression"</a>.)</p><p></p><p class="bulletIndent1">Rarely, dominant-negative mutations in the GH gene are associated with inherited isolated GH deficiency syndromes [<a href="#rid4">4</a>]. Mutations in the <em>Prop-1</em> gene (which is necessary for the differentiation of a cell type that is a precursor to somatotroph, lactotroph, thyrotroph, and gonadotroph cells) and in the <em>POU1F1 </em>(Pit-1) gene (which acts temporally just after <em>Prop-1</em> and is necessary for the differentiation of a cell type that is a precursor of somatotroph, lactotroph, and, to a lesser degree, thyrotroph cells) also account for rare cases of GH deficiency that are usually accompanied by other pituitary hormone deficiencies [<a href="#rid4">4-8</a>]. (See  <a class="medical medical_review" href="/z/d/html/5842.html" rel="external">"Diagnosis of growth hormone deficiency in children", section on 'Molecular genetics of growth hormone deficiency'</a> and  <a class="medical medical_review" href="/z/d/html/6636.html" rel="external">"Causes of hypopituitarism"</a>.)</p><p></p><p class="headingAnchor" id="H3"><span class="h1">GH SECRETION</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Regulators – </strong>Growth hormone (GH) secretion is directly controlled by hypothalamic and peripheral factors acting on the somatotrophs [<a href="#rid9">9-12</a>]. Hypothalamic growth hormone-releasing hormone (GHRH) and somatostatin (SRIH) stimulate and inhibit GH secretion, respectively [<a href="#rid2">2,13</a>]. These hormones act by binding to specific cell-surface receptors on the somatotroph cells (<a class="graphic graphic_figure graphicRef131558" href="/z/d/graphic/131558.html" rel="external">figure 1</a>).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Daily secretory rates – </strong>Daily GH secretory rates decline from a peak of approximately 150 mcg/kg during puberty to approximately 25 mcg/kg by age 55 years; this decline parallels the age-related decline in body mass index [<a href="#rid14">14</a>]. Thus, GH production falls by approximately 50 percent every seven years [<a href="#rid14">14</a>]. The serum half-life of GH is approximately 14 minutes.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Other nonpituitary tissues </strong>–<strong> </strong>GH is also produced in nonpituitary tissues, including colon and breast, and appears to regulate local cell proliferation [<a href="#rid15">15</a>].</p><p></p><p class="headingAnchor" id="H4"><span class="h2">Growth hormone-releasing hormone</span><span class="headingEndMark"> — </span>GHRH stimulates GH transcription and secretion and also somatotroph proliferation [<a href="#rid16">16</a>]. The GHRH receptor is a cell surface-associated, seven membrane-spanning domain protein linked to a G protein (Gs) that, after ligand-induced activation, stimulates intracellular cyclic adenosine monophosphate (cAMP) production [<a href="#rid17">17</a>]. (See  <a class="medical medical_review" href="/z/d/html/3804.html" rel="external">"Peptide hormone signal transduction and regulation"</a>.). </p><p>The gastrointestinal peptide, ghrelin, specifically induces GH secretion [<a href="#rid18">18</a>], and the ghrelin receptor is expressed on the anterior pituitary [<a href="#rid19">19</a>]. Ghrelin is synthesized in the stomach and is an important nutritional regulator of GH secretion. Mediated by GH, ghrelin acts to maintain blood sugar levels during starvation [<a href="#rid20">20</a>]. (See  <a class="medical medical_review" href="/z/d/html/5380.html" rel="external">"Ghrelin"</a>.)</p><p class="headingAnchor" id="H5"><span class="h2">Hypothalamic somatostatin</span><span class="headingEndMark"> — </span>Somatostatin binds to five distinct receptor subtypes (SST1-SST5) [<a href="#rid21">21</a>]. Although somatotrophs express four of these subtypes (to the exclusion of SST-4), SST2 and SST5 preferentially signal to suppress the secretion in the pituitary of GH (and thyrotropin [TSH]) [<a href="#rid22">22</a>]. The role of pituitary SST1 and SST3 receptors is not known. (See  <a class="medical medical_review" href="/z/d/html/2579.html" rel="external">"Physiology of somatostatin and its analogues", section on 'Receptors'</a>.)</p><p class="headingAnchor" id="H6"><span class="h2">Other regulators</span><span class="headingEndMark"> — </span>Insulin-like growth factor 1 (IGF-1), which mediates most of the peripheral actions of GH, inhibits GH secretion (<a class="graphic graphic_figure graphicRef131558" href="/z/d/graphic/131558.html" rel="external">figure 1</a>). (See  <a class="medical medical_review" href="/z/d/html/3801.html" rel="external">"Physiology of insulin-like growth factor 1"</a>.)</p><p>GH secretion is also affected by nutritional factors. GH secretion is increased in subjects who are malnourished or fasting [<a href="#rid14">14</a>], and it is stimulated by high protein meals and intravenously administered amino acids [<a href="#rid23">23</a>]. In contrast, hyperglycemia and leptin inhibit GH secretion [<a href="#rid24">24</a>].</p><p>Thus, there appears to be a complex interaction of nutritional factors and hypothalamic appetite-regulating peptides in mediating GH secretion. Insulin-induced hypoglycemia is a powerful stimulus to GH release that may be used as a provocative test for the diagnosis of impaired GH reserve. (See  <a class="medical medical_review" href="/z/d/html/6639.html" rel="external">"Diagnostic testing for hypopituitarism", section on 'Growth hormone'</a>.)</p><p>A number of other factors influence GH secretion; these effects on GH secretion include:</p><p class="bulletIndent1"><span class="glyph">●</span>Stimulation by estrogen and inhibition by glucocorticoid excess [<a href="#rid25">25</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Stimulation by dopamine, <a class="drug drug_general" data-topicid="9374" href="/z/d/drug information/9374.html" rel="external">apomorphine</a> (a dopamine-receptor agonist), alpha-adrenergic agonists, and beta-adrenergic antagonists. In addition to increasing basal GH secretion, beta-adrenergic antagonists augment the responses to GHRH and insulin-induced hypoglycemia.</p><p></p><p class="headingAnchor" id="H7"><span class="h2">Pulsatile secretion</span><span class="headingEndMark"> — </span>GH secretion is pulsatile; between pulses, serum GH concentration may be undetectable unless an ultrasensitive assay is employed. It is thought that the pulsatile bursts of GH release are mediated by reduction in tonic inhibition by somatostatin, perhaps in association with bursts of GHRH [<a href="#rid13">13,25</a>].</p><p class="headingAnchor" id="H201813195"><span class="h3">24-hour sampling</span><span class="headingEndMark"> — </span>Twenty-minute GH sampling for 24 hours allows accurate assessment of mean serum GH concentrations. Mean (±SE) nighttime serum GH concentrations are 1.0±0.2 ng/mL and mean daytime concentrations are 0.6±0.1 ng/mL in normal adults. Using ultrasensitive GH assays, normal GH concentrations may even be lower. Peak serum GH concentrations are 4.3±0.7 ng/mL at night and 2.7±0.5 ng/mL during the day [<a href="#rid26">26</a>]. GH secretion is lower in older and obese subjects and is higher during puberty and when corrected for body surface area in neonates [<a href="#rid27">27,28</a>].</p><p>Peak GH secretory activity occurs within an hour after the onset of deep sleep. Exercise, physical activity, trauma, and sepsis are associated with increased GH secretion. With exercise, as an example, serum GH concentrations may increase to 20 to 30 ng/mL [<a href="#rid29">29</a>]. Integrated 24-hour GH secretion is higher in women than in men and increases in postmenopausal women during estrogen replacement [<a href="#rid30">30</a>].</p><p>The development of ultrasensitive GH assays has facilitated detailed studies of GH secretory dynamics. Studies in which serum GH was measured using an ultrasensitive, chemiluminescence-based assay with a sensitivity of 0.002 ng/mL have revealed the following results:</p><p class="bulletIndent1"><span class="glyph">●</span>There are approximately 10 pulses of GH secretion per day, lasting approximately 90 minutes and separated by approximately 128 minutes [<a href="#rid26">26</a>]. Thus, approximately 50 percent of frequently collected samples collected during the day in normal subjects have undetectable serum GH concentrations, and GH is undetectable in over 95 percent of samples in obese or older subjects [<a href="#rid30">30</a>]. As a result, random measurement of serum GH will likely not distinguish patients with GH deficiency or GH excess from normal subjects [<a href="#rid26">26,31,32</a>]. (See  <a class="medical medical_review" href="/z/d/html/6639.html" rel="external">"Diagnostic testing for hypopituitarism", section on 'Growth hormone'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Sex-specific differences in GH pulse amplitude and mass are distinguishable. As an example, glucose loading suppresses serum GH concentrations to &lt;0.7 ng/mL in women and &lt;0.07 ng/mL in men; however, this probably reflects the lower basal concentrations in men rather than a greater suppressive effect of glucose loading [<a href="#rid30">30</a>].</p><p></p><p>In summary, GH pulsatility and net hormone secretion reflect the tonic interaction of multiple complex inputs but is ultimately determined by the balanced control of GHRH and somatostatin and perhaps ghrelin action. The pattern of GH secretion also impacts upon GH action in that several tissue responses to GH appear to be determined by the secretory patterns of GH rather than the absolute amount of GH that is secreted. The greater GH pulsatility in men, as compared with the relatively continuous GH secretion in women, may be a determinant of linear growth patterns, liver enzyme induction, and GH-signaling molecule (STAT 5b) activity [<a href="#rid33">33,34</a>].</p><p class="headingAnchor" id="H8"><span class="h1">ACTIONS OF GH</span></p><p class="headingAnchor" id="H3140446695"><span class="h2">Specific effects</span><span class="headingEndMark"> — </span>Growth hormone (GH) stimulates linear growth in children by acting directly and indirectly (via the synthesis of insulin-like growth factor 1 [IGF-1]) on the epiphyseal plates of long bones. GH also has specific metabolic actions in the adult including [<a href="#rid35">35</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Increased lipolysis and lipid oxidation, which leads to mobilization of stored triglyceride</p><p class="bulletIndent1"><span class="glyph">●</span>Stimulation of protein synthesis</p><p class="bulletIndent1"><span class="glyph">●</span>Antagonism of insulin action, which may lead to glucose intolerance, diabetes, and features of the metabolic syndrome when GH is in excess</p><p class="bulletIndent1"><span class="glyph">●</span>Phosphate, water, and sodium retention</p><p></p><p>These target tissue actions result in maintenance of adult cardiac function, glucose homeostasis, maintenance of bone mineralization, appropriate balance of adipose lipogenesis and lipolysis, and skeletal muscle anabolism. All these functions are attenuated in patients with GH deficiency, and replacement of GH reverses the abnormalities (<a class="graphic graphic_figure graphicRef131559" href="/z/d/graphic/131559.html" rel="external">figure 2</a>).</p><p class="headingAnchor" id="H9"><span class="h2">GH receptor</span><span class="headingEndMark"> — </span>Growth hormone (GH) acts by binding to a specific receptor homodimer, located mostly in the liver, and inducing intracellular signaling by a phosphorylation cascade involving the JAK/STAT (signal transducing activators of transcription) pathway. Its predominant action is to stimulate hepatic synthesis and secretion of IGF-1, a potent growth and differentiation factor [<a href="#rid1">1,36</a>].</p><p>The GH receptor is a 70 kd protein that is a member of the class of receptors common to the cytokine/hematopoietin superfamily [<a href="#rid1">1</a>]. The receptor consists of an extracellular ligand-binding domain, a single membrane-spanning domain, and a cytoplasmic signaling component. Circulating GH-binding proteins are fragments of the receptor that bind GH [<a href="#rid37">37</a>].</p><p>A single GH molecule complexes with two GH receptor molecules, followed by rapid internal rotation, and activation of JAK2 tyrosine kinase, leading to phosphorylation of several cytoplasmic signaling molecules that determine transcription of cell proliferation and differentiated function genes.</p><p>The STAT proteins comprise important signaling components for GH action. These cytoplasmic proteins are phosphorylated by JAK2 and directly translocate to the cell nucleus, where they elicit GH-specific target gene effects by binding to nuclear DNA [<a href="#rid1">1</a>]. STAT proteins 1 and 5 may also interact more directly with the GH receptor molecule [<a href="#rid38">38</a>].</p><p>As a differentiating and growth factor, IGF-1 is a critical protein induced by GH and is likely responsible for most of the linear growth-promoting activities of GH [<a href="#rid39">39</a>]. Furthermore, IGF-1 also directly inhibits GH secretion [<a href="#rid39">39</a>] and GH receptor function [<a href="#rid40">40</a>] by a negative feedback regulation loop. Other actions of GH include stimulation of c-fos and IRS-1 phosphorylation.</p><p>Mutations of the GH receptor are associated with partial or complete GH insensitivity and growth failure (Laron dwarfism) (see  <a class="medical medical_review" href="/z/d/html/15796.html" rel="external">"Growth hormone insensitivity syndromes", section on 'Growth hormone receptor mutations (Laron syndrome)'</a>). Laron dwarfism is associated with normal or high serum GH concentrations, low serum GH-binding protein concentrations, and low serum IGF-1 concentrations. Over 30 different homozygous or heterozygous exonic and intronic mutations of the receptor have been described, most of which are found in its extracellular ligand-binding domain. STAT mutations have also reported leading to short stature [<a href="#rid1">1,7,38</a>].</p><p>The physiology of IGF-1, which mediates most of the peripheral actions of GH, is discussed separately. (See  <a class="medical medical_review" href="/z/d/html/3801.html" rel="external">"Physiology of insulin-like growth factor 1"</a>.)</p><p class="headingAnchor" id="H201813208"><span class="h1">SUMMARY</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Growth hormone production and secretion – </strong>Growth hormone (GH), the most abundant anterior pituitary hormone, is produced by the pituitary somatotroph cells. GH production begins early in fetal life and continues throughout childhood and adult life, although at a progressively lower rate in the latter. (See <a class="local">'Introduction'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Regulation of the pituitary </strong><strong><em>GH1 </em></strong><strong>gene </strong>–<strong> </strong>Regulation of the pituitary <em>GH1</em> gene appears to be under complex hormonal, developmental, and tissue-specific control mediated by regulatory elements of the gene. The tissue-specific development of somatotrophs and expression of GH appear to be largely determined by the POU1F1 (Pit-1) transcription factor. Rarely, dominant-negative mutations in the GH gene are associated with inherited isolated GH deficiency syndromes. (See <a class="local">'GH gene'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>GH secretion </strong>–<strong> </strong>GH secretion is directly controlled by hypothalamic and peripheral factors acting on the somatotrophs. Hypothalamic growth hormone-releasing hormone (GHRH) and somatostatin (SRIH) stimulate and inhibit GH secretion, respectively. These hormones act by binding to specific cell-surface receptors on the somatotroph cells. GHRH stimulates GH transcription and secretion, and also somatotroph proliferation (<a class="graphic graphic_figure graphicRef131558" href="/z/d/graphic/131558.html" rel="external">figure 1</a>). (See <a class="local">'GH secretion'</a> above.)</p><p></p><p class="bulletIndent1">Daily GH secretory rates decline from a peak of approximately 150 mcg/kg during puberty to approximately 25 mcg/kg by age 55 years; this decline parallels the age-related decline in muscle mass. (See <a class="local">'GH secretion'</a> above.)</p><p></p><p class="bulletIndent1">GH secretion is pulsatile. There are approximately 10 pulses of GH secretion per day, lasting approximately 90 minutes and separated by approximately 128 minutes. Thus, approximately 50 percent of samples collected during the day in normal subjects have undetectable serum GH concentrations. In addition, GH is undetectable in over 95 percent of samples in obese or older subjects. (See <a class="local">'Pulsatile secretion'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>GH action </strong>–<strong> </strong>The predominant action of GH is to stimulate hepatic synthesis and secretion of insulin-like growth factor 1 (IGF-1), a potent growth and differentiation factor. As a differentiating and growth factor, IGF-1 is a critical protein induced by GH and is likely responsible for most of the growth-promoting activities of GH. (See  <a class="medical medical_review" href="/z/d/html/3801.html" rel="external">"Physiology of insulin-like growth factor 1"</a>.)</p><p></p><p class="bulletIndent1">The target tissue actions of GH result in maintenance of adult cardiac function, glucose homeostasis, maintenance of bone mineralization, appropriate balance of adipose lipogenesis and lipolysis, and skeletal muscle anabolism (<a class="graphic graphic_figure graphicRef131559" href="/z/d/graphic/131559.html" rel="external">figure 2</a>).</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Brooks AJ, Waters MJ. The growth hormone receptor: mechanism of activation and clinical implications. Nat Rev Endocrinol 2010; 6:515.</a></li><li><a class="nounderline abstract_t">Ho Y, Liebhaber SA, Cooke NE. Activation of the human GH gene cluster: roles for targeted chromatin modification. Trends Endocrinol Metab 2004; 15:40.</a></li><li><a class="nounderline abstract_t">Voss JW, Rosenfeld MG. Anterior pituitary development: short tales from dwarf mice. Cell 1992; 70:527.</a></li><li><a class="nounderline abstract_t">Procter AM, Phillips JA 3rd, Cooper DN. The molecular genetics of growth hormone deficiency. Hum Genet 1998; 103:255.</a></li><li><a class="nounderline abstract_t">Wu W, Cogan JD, Pfäffle RW, et al. Mutations in PROP1 cause familial combined pituitary hormone deficiency. Nat Genet 1998; 18:147.</a></li><li><a class="nounderline abstract_t">Pellegrini-Bouiller I, Bélicar P, Barlier A, et al. A new mutation of the gene encoding the transcription factor Pit-1 is responsible for combined pituitary hormone deficiency. J Clin Endocrinol Metab 1996; 81:2790.</a></li><li><a class="nounderline abstract_t">Mullis PE. Genetics of GHRH, GHRH-receptor, GH and GH-receptor: its impact on pharmacogenetics. Best Pract Res Clin Endocrinol Metab 2011; 25:25.</a></li><li><a class="nounderline abstract_t">Mullis PE. Genetics of growth hormone deficiency. Endocrinol Metab Clin North Am 2007; 36:17.</a></li><li><a class="nounderline abstract_t">Leung KC, Ho KK. Measurement of growth hormone, insulin-like growth factor I and their binding proteins: the clinical aspects. Clin Chim Acta 2001; 313:119.</a></li><li><a class="nounderline abstract_t">Murray PG, Higham CE, Clayton PE. 60 YEARS OF NEUROENDOCRINOLOGY: The hypothalamo-GH axis: the past 60 years. J Endocrinol 2015; 226:T123.</a></li><li><a class="nounderline abstract_t">Melmed S. Pathogenesis and Diagnosis of Growth Hormone Deficiency in Adults. N Engl J Med 2019; 380:2551.</a></li><li><a class="nounderline abstract_t">Buchman M, Bell S, Kopchick JJ. Growth Hormone Discovery and Structure. Pediatr Endocrinol Rev 2018; 16:2.</a></li><li><a class="nounderline abstract_t">Hartman ML, Veldhuis JD, Thorner MO. Normal control of growth hormone secretion. Horm Res 1993; 40:37.</a></li><li><a class="nounderline abstract_t">Giustina A, Veldhuis JD. Pathophysiology of the neuroregulation of growth hormone secretion in experimental animals and the human. Endocr Rev 1998; 19:717.</a></li><li><a class="nounderline abstract_t">Chesnokova V, Zonis S, Zhou C, et al. Growth hormone is permissive for neoplastic colon growth. Proc Natl Acad Sci U S A 2016; 113:E3250.</a></li><li><a class="nounderline abstract_t">Frohman LA, Jansson JO. Growth hormone-releasing hormone. Endocr Rev 1986; 7:223.</a></li><li><a class="nounderline abstract_t">Chanson P, Cailleux-Bounacer A, Kuhn JM, et al. Comparative validation of the growth hormone-releasing hormone and arginine test for the diagnosis of adult growth hormone deficiency using a growth hormone assay conforming to recent international recommendations. J Clin Endocrinol Metab 2010; 95:3684.</a></li><li><a class="nounderline abstract_t">Kojima M, Hosoda H, Date Y, et al. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 1999; 402:656.</a></li><li><a class="nounderline abstract_t">Pong SS, Chaung LY, Dean DC, et al. Identification of a new G-protein-linked receptor for growth hormone secretagogues. Mol Endocrinol 1996; 10:57.</a></li><li><a class="nounderline abstract_t">Zhao TJ, Liang G, Li RL, et al. Ghrelin O-acyltransferase (GOAT) is essential for growth hormone-mediated survival of calorie-restricted mice. Proc Natl Acad Sci U S A 2010; 107:7467.</a></li><li><a class="nounderline abstract_t">Günther T, Tulipano G, Dournaud P, et al. International Union of Basic and Clinical Pharmacology. CV. Somatostatin Receptors: Structure, Function, Ligands, and New Nomenclature. Pharmacol Rev 2018; 70:763.</a></li><li><a class="nounderline abstract_t">Ben-Shlomo A, Melmed S. Pituitary somatostatin receptor signaling. Trends Endocrinol Metab 2010; 21:123.</a></li><li><a class="nounderline abstract_t">Jaffe CA, DeMott-Friberg R, Barkan AL. Endogenous growth hormone (GH)-releasing hormone is required for GH responses to pharmacological stimuli. J Clin Invest 1996; 97:934.</a></li><li><a class="nounderline abstract_t">Unger RH. The hyperleptinemia of obesity-regulator of caloric surpluses. Cell 2004; 117:145.</a></li><li><a class="nounderline abstract_t">Van Cauter E, Leproult R, Plat L. Age-related changes in slow wave sleep and REM sleep and relationship with growth hormone and cortisol levels in healthy men. JAMA 2000; 284:861.</a></li><li><a class="nounderline abstract_t">Toogood AA, Nass RM, Pezzoli SS, et al. Preservation of growth hormone pulsatility despite pituitary pathology, surgery, and irradiation. J Clin Endocrinol Metab 1997; 82:2215.</a></li><li><a class="nounderline abstract_t">Reutens AT, Veldhuis JD, Hoffman DM, et al. A highly sensitive growth hormone (GH) enzyme-linked immunosorbent assay uncovers increased contribution of a tonic mode of GH secretion in adults with organic GH deficiency. J Clin Endocrinol Metab 1996; 81:1591.</a></li><li><a class="nounderline abstract_t">Goldenberg N, Barkan A. Factors regulating growth hormone secretion in humans. Endocrinol Metab Clin North Am 2007; 36:37.</a></li><li><a class="nounderline abstract_t">Salvatori R. Growth hormone and IGF-1. Rev Endocr Metab Disord 2004; 5:15.</a></li><li><a class="nounderline abstract_t">Chapman IM, Hartman ML, Straume M, et al. Enhanced sensitivity growth hormone (GH) chemiluminescence assay reveals lower postglucose nadir GH concentrations in men than women. J Clin Endocrinol Metab 1994; 78:1312.</a></li><li><a class="nounderline abstract_t">Iranmanesh A, Grisso B, Veldhuis JD. Low basal and persistent pulsatile growth hormone secretion are revealed in normal and hyposomatotropic men studied with a new ultrasensitive chemiluminescence assay. J Clin Endocrinol Metab 1994; 78:526.</a></li><li><a class="nounderline abstract_t">Reutens AT, Hoffman DM, Leung KC, Ho KK. Evaluation and application of a highly sensitive assay for serum growth hormone (GH) in the study of adult GH deficiency. J Clin Endocrinol Metab 1995; 80:480.</a></li><li><a class="nounderline abstract_t">Woelfle J, Chia DJ, Rotwein P. Mechanisms of growth hormone (GH) action. Identification of conserved Stat5 binding sites that mediate GH-induced insulin-like growth factor-I gene activation. J Biol Chem 2003; 278:51261.</a></li><li><a class="nounderline abstract_t">Bidlingmaier M, Freda PU. Measurement of human growth hormone by immunoassays: current status, unsolved problems and clinical consequences. Growth Horm IGF Res 2010; 20:19.</a></li><li><a class="nounderline abstract_t">Ho KK, O'Sullivan AJ, Burt MG. The physiology of growth hormone (GH) in adults: translational journey to GH replacement therapy. J Endocrinol 2023; 257.</a></li><li><a class="nounderline abstract_t">Carter-Su C, Schwartz J, Argetsinger LS. Growth hormone signaling pathways. Growth Horm IGF Res 2016; 28:11.</a></li><li><a class="nounderline abstract_t">Barnard R, Waters MJ. The serum growth hormone binding protein: pregnant with possibilities. J Endocrinol 1997; 153:1.</a></li><li><a class="nounderline abstract_t">Eugster EA, Pescovitz OH. New revelations about the role of STATs in stature. N Engl J Med 2003; 349:1110.</a></li><li><a class="nounderline abstract_t">Frank SJ. Growth hormone signalling and its regulation: preventing too much of a good thing. Growth Horm IGF Res 2001; 11:201.</a></li><li><a class="nounderline abstract_t">Leung KC, Waters MJ, Markus I, et al. Insulin and insulin-like growth factor-I acutely inhibit surface translocation of growth hormone receptors in osteoblasts: a novel mechanism of growth hormone receptor regulation. Proc Natl Acad Sci U S A 1997; 94:11381.</a></li></ol></div><div id="topicVersionRevision">Topic 3802 Version 20.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20664532" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : The growth hormone receptor: mechanism of activation and clinical implications.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14693425" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Activation of the human GH gene cluster: roles for targeted chromatin modification.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1505020" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Anterior pituitary development: short tales from dwarf mice.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9799079" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : The molecular genetics of growth hormone deficiency.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9462743" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Mutations in PROP1 cause familial combined pituitary hormone deficiency.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8768831" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : A new mutation of the gene encoding the transcription factor Pit-1 is responsible for combined pituitary hormone deficiency.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21396573" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Genetics of GHRH, GHRH-receptor, GH and GH-receptor: its impact on pharmacogenetics.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17336732" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Genetics of growth hormone deficiency.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11694248" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Measurement of growth hormone, insulin-like growth factor I and their binding proteins: the clinical aspects.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26040485" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : 60 YEARS OF NEUROENDOCRINOLOGY: The hypothalamo-GH axis: the past 60 years.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31242363" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Pathogenesis and Diagnosis of Growth Hormone Deficiency in Adults.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30378777" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Growth Hormone Discovery and Structure.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8300049" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Normal control of growth hormone secretion.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9861545" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Pathophysiology of the neuroregulation of growth hormone secretion in experimental animals and the human.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27226307" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Growth hormone is permissive for neoplastic colon growth.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2874984" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Growth hormone-releasing hormone.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20484474" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Comparative validation of the growth hormone-releasing hormone and arginine test for the diagnosis of adult growth hormone deficiency using a growth hormone assay conforming to recent international recommendations.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10604470" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Ghrelin is a growth-hormone-releasing acylated peptide from stomach.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8838145" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Identification of a new G-protein-linked receptor for growth hormone secretagogues.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20231469" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Ghrelin O-acyltransferase (GOAT) is essential for growth hormone-mediated survival of calorie-restricted mice.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30232095" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : International Union of Basic and Clinical Pharmacology. CV. Somatostatin Receptors: Structure, Function, Ligands, and New Nomenclature.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20149677" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Pituitary somatostatin receptor signaling.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8613546" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Endogenous growth hormone (GH)-releasing hormone is required for GH responses to pharmacological stimuli.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15084251" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : The hyperleptinemia of obesity-regulator of caloric surpluses.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10938176" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Age-related changes in slow wave sleep and REM sleep and relationship with growth hormone and cortisol levels in healthy men.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9215297" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Preservation of growth hormone pulsatility despite pituitary pathology, surgery, and irradiation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8636373" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : A highly sensitive growth hormone (GH) enzyme-linked immunosorbent assay uncovers increased contribution of a tonic mode of GH secretion in adults with organic GH deficiency.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17336733" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Factors regulating growth hormone secretion in humans.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14966386" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Growth hormone and IGF-1.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8200931" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Enhanced sensitivity growth hormone (GH) chemiluminescence assay reveals lower postglucose nadir GH concentrations in men than women.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8126122" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Low basal and persistent pulsatile growth hormone secretion are revealed in normal and hyposomatotropic men studied with a new ultrasensitive chemiluminescence assay.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7852508" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Evaluation and application of a highly sensitive assay for serum growth hormone (GH) in the study of adult GH deficiency.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14532269" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Mechanisms of growth hormone (GH) action. Identification of conserved Stat5 binding sites that mediate GH-induced insulin-like growth factor-I gene activation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19818659" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Measurement of human growth hormone by immunoassays: current status, unsolved problems and clinical consequences.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36524723" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : The physiology of growth hormone (GH) in adults: translational journey to GH replacement therapy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26421979" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Growth hormone signaling pathways.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9135564" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : The serum growth hormone binding protein: pregnant with possibilities.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/13679524" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : New revelations about the role of STATs in stature.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11735235" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Growth hormone signalling and its regulation: preventing too much of a good thing.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9326618" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Insulin and insulin-like growth factor-I acutely inhibit surface translocation of growth hormone receptors in osteoblasts: a novel mechanism of growth hormone receptor regulation.</p>
</a>
</div>
</div>
</div>
</div>
</section>
</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->
<!-- End Footer Area -->
<!-- Back to top -->
<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->
<!-- Prpper JS -->
<!-- Bootstrap Min JS -->
<!-- Classy Nav Min Js -->
<!-- Owl Carousel Min Js -->
<!-- Magnific Popup JS -->
<!-- CounterUp JS -->
<!-- Waypoints JS -->
<!-- Form Validator Min JS -->
<!-- Contact Form Min JS -->
<!-- Main JS -->
<!-- Global site tag (gtag.js) - Google Analytics -->
</body>
</html>
